Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection

Shock

Volumn 23, Issue 3, 2005, Pages 224-232

  Lyuksutova, Olga I ^a   Murphey, Erle D ^a   Toliver Kinsky, Tracy E ^a   Lin, Cheng Y ^a   Cui, Weihua ^a   Williams, David L ^b   Sherwood, Edward R ^a,c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b East Tennessee State University   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cytokines; Immunomodulation; Infection; Shock; Trauma

Indexed keywords

GLUCAN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PHOSPHATE; RINGER LACTATE SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY SURFACE; BURN INFECTION; CONTROLLED STUDY; FEMALE; HEART; IMMUNOMODULATION; INFLAMMATION; LUNG; MOUSE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SPLEEN; SURVIVAL;

ACID-BASE EQUILIBRIUM; ANIMALS; BURNS; CHEMOKINES; FEMALE; GENE EXPRESSION; GLUCANS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLAMMATION; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; PSEUDOMONAS INFECTIONS; RNA, MESSENGER; WOUND INFECTION;

EID: 14344250532     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000151864.79293.41     Document Type: Article

References (52)

1. Cone JB, Wallace BH, Lubansky HJ, Caldwell FT: Manipulation of the inflammatory response to burn injury. J Trauma 43:41-45, 1997.
2. Demling RH, LaLonde C, Liu YP, Zhu DG: The lung inflammatory response to thermal injury: relationship between physiologic and histologic changes. Surgery 106:52-59, 1989.
3. Nguyen TT, Gilpin DA, Meyer NA, Herndon DN: Current treatment of severely burned patients. Ann Surg 223:14-25, 1996.
4. Jeschke MG, Barrow RE, Suzuki F, Rai J, Benjamin D, Herndon DN: IGF-I/IGFBP-3 equilibrates ratios of pro- to anti-inflammatory cytokines, which are predictors for organ function in severely burned pediatric patients. Mol Med 8:238-246, 2002.
5. Bhatia M, Moochhala S: Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 202:145-156, 2004.
6. Barret JP, Herndon DN: Modulation of inflammatory and catabolic responses in severely burned children by early burn wound excision in the first 24 hours. Arch Surg 138:127-132, 2003.
7. Wolf SE, Rose JK, Desai MH, Mileski JP, Barrow RE, Herndon DN: Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80% TBSA burns (> or = 70% full-thickness). Ann Surg 225:554-565, 1997.
8. Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR: Reversal of catabolism by β-blockade after severe burns. N Engl J Med 345:1223-1229, 2001.
9. Murphy KD, Lee JO, Herndon DN: Current pharmacotherapy for the treatment of severe burns. Expert Opin Pharmacother 4:369-384, 2003.
10. Appelgren P, Bjornhagen V, Bragderyd K, Jonsson CE, Ransjo U: A prospective study of infections in burn patients. Burns 28:39-46, 2002.
11. Rodgers GL, Mortensen J, Fisher MC, Lo A, Cresswell A, Long SS: Predictors of infectious complications after burn injuries in children. Pediatr Infect Dis J 19:990-995, 2000.
12. Shires GT, Dineen P: Sepsis following burns, trauma, and intra-abdominal infections. Arch Intern Med 142:2012-2022, 1982.
13. Ugburo AO, Atoyebi OA, Oyeneyin JO, Sowemimo GO: An evaluation of the role of systemic antibiotic prophylaxis in the control of burn wound infection at the Lagos University Teaching Hospital. Burns 30:43-48, 2004.
14. Agnihotri N, Gupta V, Joshi RM: Aerobic bacterial isolates from burn wound infections and their antibiograms: five-year study. Burns 30:241-243, 2004.
15. Erol S, Altoparlak U, Akcay MN, Celebi F, Parlak M: Changes of microbial flora and wound colonization in burned patients. Burns 30:357-361, 2004.
16. Rumbaugh KP, Griswold JA, Iglewski BH, Hamood AN: Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect Immun 67:5854-5862, 1999.
17. Toliver-Kinsky TE, Varma TK, Lin CY, Herndon DN, Sherwood ER: Interferon-γ production is suppressed in thermally injured mice: decreased production of regulatory cytokines and corresponding receptors. Shock 18:322-330, 2002.
18. Yadavalli GK, Auletta JJ, Gould MP, Salata RA, Lee JH, Heinzel FP: Deactivation of the innate cellular immune response following endotoxic and surgical injury. Exp Mol Pathol 71:209-221, 2001.
19. Klimpel GR, Herndon DN, Fons M, Albrecht T, Asuncion MT, Chin R, Stein MD: Defective NK cell activity following thermal injury. Clin Exp Immunol 66:384-392, 1986.
20. Rodeberg DA, Bass RC, Alexander JW, Warden GD, Babcock GF: Neutrophils from burn patients are unable to increase the expression of CD11b/CD18 in response to inflammatory stimuli. J Leukocyteol 61:575-582, 1997.
21. Teodorczyk-Injeyan JA, Sparkes BG, Mills GB, Peters WJ, Falk RE: Impairment of T cell activation in burn patients: a possible mechanism of thermal injury-induced immunosuppression. Clin Exp Immunol 65:570-581, 1986.
22. Sherwood ER, Varma TK, Fram RY, Lin CY, Koutrouvelis AP, Toliver-Kinsky TE: Glucan phosphate potentiates endotoxin-induced interferon-γ expression in immunocompetent mice, but attenuates induction of endotoxin tolerance. Clin Sci 101:541-550, 2001.
23. Williams DL, McNamee RB, Jones EL, Pretus HA, Ensley HE, Browder IW, Di Luzio NR: A method for the solubilization of a (1→3)-β-D-glucan isolated from Saccharomyces cerevisiae. Carbohydr Res 219:203-213, 1991.
24. Williams DL, Li C, Ha T, Ozment-Skelton T, Kalbfleisch JH, Preiszner J, Brooks L, Breuel K, Schweitzer JB: Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J Immunol 172:449-456, 2004.
25. Williams DL, Browder W, McNamee R, Di Luzio NR: Glucan immunomodulation in experimental E. coli sepsis. Adv Exp Med Biol 155:701-706, 1982.
26. Browder W, Williams D, Pretus H, Olivero G, Enrichens F, Mao P, Franchello A: Beneficial effect of enhanced macrophage function in the trauma patient. Ann Surg 211:605-612, 1990.
27. de Felippe J Jr., da Rocha e Silva Jr., Maciel FM, Soares Ade M, Mendes NF: Infection prevention in patients with severe multiple trauma with the immunomodulator β, 1-3 polyglucose (glucan). Surg Gynecol Obstet 177:383-388, 1993.
28. Babineau TJ, Marcello P, Swails W, Kenler A, Bistrian B, Forse RA: Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann Surg 220:601-609, 1994.
29. Williams DL, Ha T, Li C, Kalbfleisch JH, Ferguson DA Jr.: Early activation of hepatic NFκB and NF-IL6 in polymicrobial sepsis correlates with bacteremia, cytokine expression, and mortality. Ann Surg 230:95-104, 1999.
30. Toliver-Kinsky TE, Lin CY, Herndon DN, Sherwood ER: Stimulation of hematopoiesis by the Fms-like tyrosine kinase 3 ligand restores bacterial induction of Th1 cytokines in thermally injured mice. Infect Immun 71:3058-3067, 2003.
31. Jeschke MG, Einspanier R, Klein D, Jauch KW: Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 8:443-450, 2002.
32. Dehne MG, Sablotzki A, Hoffmann A, Muhling J, Dietrich FE, Hempelmann G: Alterations of acute phase reaction and cytokine production in patients following severe burn injury. Burns 28:535-542, 2002.
33. Papp A, Uusaro A, Parviainen I, Hartikainen J, Ruokonen E: Myocardial function and haemodynamics in extensive burn trauma: evaluation by clinical signs, invasive monitoring, echocardiography and cytokine concentrations. A prospective clinical study. Acta Anaesthesiol Scand 47:1257-1263, 2003.
34. Maass DL, Hybki DP, White J, Horton JW: The time course of cardiac NF-κB activation and TNF-α secretion by cardiac myocytes after burn injury: contribution to burn-related cardiac contractile dysfunction. Shock 17:293-299, 2002.
35. Biffl WL, Moore EE, Moore FA, Peterson VM: Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? Ann Surg 224:647-664, 1996.
36. Jeschke MG, Klein D, Herndon DN: Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 239:553-560, 2004.
37. Maass DL, White J, Horton JW: IL-1β and IL-6 act synergistically with TNF-α to alter cardiac contractile function after burn trauma. Shock 18:360-366, 2002.
38. Williams DL, Ha T, Li C, Kalbfleisch JH, Laffan JJ, Ferguson DA: Inhibiting early activation of tissue nuclear factor-κB and nuclear factor interleukin 6 with (1→3)-β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery 126:54-65, 1999.
39. Williams DL, Ha T, Li C, Kalbfleisch JH, Schweitzer J, Vogt W, Browder IW: Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med 31:1808-1818, 2003.
40. Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL, Browder W, Williams DL: Modulating Toll-like receptor mediated signaling by (1→3)-β-D-glucan rapidly induces cardioprotection. Cardiovasc Res 61:538-547, 2004.
41. Aikawa N, Ishibiki K, Naito C, Abe O, Yamamoto S, Motegi M, Sudo M: Individualized fluid resuscitation based on haemodynamic monitoring in the management of extensive burns. Burns 8:249-255, 1982.
42. Soltero RG, Hansbrough JF: The effects of diaspirin cross-linked hemoglobin on hemodynamics, metabolic acidosis, and survival in burned rats. J Trauma 46:286-291, 1999.
43. Barton RG, Saffle JR, Morris SE, Mone M, Davis B, Shelby J: Resuscitation of thermally injured patients with oxygen transport criteria as goals of therapy. J Burn Care Rehabil 18:1-9, 1997.
44. Williams DL, Browder IW, Di Luzio NR: Immunotherapeutic modification of Escherichia coli-induced experimental peritonitis and bacteremia by glucan. Surgery 93:448-454, 1983.
45. Williams DL, Di Luzio NR: Glucan-induced modification of experimental Staphylococcus aureus infection in normal, leukemic and immunosuppressed mice. Adv Exp Med Biol 121:291-306, 1979.
46. Lahnborg G, Hedstrom KG, Nord CE: Glucan-induced enhancement of host resistance in experimental intraabdominal sepsis. Eur Surg Res 14:401-408, 1982.
47. Tzianabos AO, Cisneros RL: Prophylaxis with the immunomodulator PGG glucan enhances antibiotic efficacy in rats infected with antibiotic-resistant bacteria. Ann N Y Acad Sci 797:285-287, 1996.
48. Estahbanati HK, Kashani PP, Ghanaatpisheh F: Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics. Burns 28:340-348. 2002.
49. Schlager T, Sadler J, Weber D, Donowitz L, Lohr J: Hospital-acquired infections in pediatric burn patients. Southern Med Assoc J 87:481-484, 1994.
50. Murphey ED, Lin CY, McGuire RW, Toliver-Kinsky T, Herndon DN, Sherwood ER: Diminished bacterial clearance is associated with decreased IL-12 and interferon-γ production but a sustained proinflammatory response in a murine model of postseptic immunosuppression. Shock 21:415-425, 2004.
51. Ayala A. Ertel W, Chaudry IH: Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock 5:79-90, 1996.
52. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, Rodrick ML: Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482-490, 1995.